NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Chinese Stocks Test Resilience Amid Iran War Uncertainty

Key Statistics:

  • CSI 300 Index: declined 3.3% on Monday, its worst performance since the global tariff shock in 2025.
  • Shanghai Composite: slipped below the psychologically important 4,000 level.
  • Market Breadth: deteriorated sharply this month, with over 1,100 stocks declining versus rising out of nearly 6,000 names.

Market Indicators

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Chinese stocks have been put to the test by the drag in the Iran war, but key market indicators signal conditions often associated with turning points. The CSI 300 Index tumbled 3.3% on Monday, its worst performance since the global tariff shock about a year ago. Another onshore benchmark slid deeper below the psychologically important 4,000 level.

Fundamentals Remain Firm

Despite the decline, fundamentals have remained firm. Over the past quarter, earnings revisions for the CSI 300 have trended higher, with analysts steadily lifting forward profit expectations even as the index has retreated. The declines have pushed the Bloomberg-estimated dividend yield on the index back to 2.7%, the highest since November.

Breadth Weakness

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Market breadth has weakened despite only modest changes in earnings expectations, suggesting that sentiment rather than fundamentals is driving flows. A further decline would mean there's limited room for things to worsen from here. Historically, such extremes have often coincided with near exhaustion in selling pressure.

Technical Indicators

The Shanghai Composite's 14-day relative strength index has slipped to 23, entering oversold territory. Similar lows were seen in April after President Donald Trump's sweeping tariffs announcement, and again in the third quarter of 2024, shortly before Beijing's policy pivot triggered a re-rating. While oversold readings aren't always a buy signal by themselves, they have typically been followed by rebounds rather than further declines.

Investor Takeaway

Investors may consider a rebound in Chinese equities as key market indicators signal potential turning points.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.